5140: Sun Pharma acquires Organon, Tata Trusts meeting agenda & the rise of domestic help on demand | Editor's Picks
About this episode
The episode discusses major developments in Indian business, including Sun Pharma's acquisition of Organon and Tata Trusts' upcoming meeting agenda.
India Inc is in the middle of a major transformation. Sun Pharma has acquired US-based Organon in the biggest-ever overseas deal by an Indian drugmaker. Tata Trusts are set to hold a crucial meeting on May 8, where issues such as a fresh term for N Chandrasekaran, the possible listing of Tata Sons, and governance matters may come up for discussion. Despite the West Asia war, early fourth-quarter earnings have surprised positively, with revenue growth hitting a three-year high and profits reaching a five-quarter peak. In capital markets, Acko is preparing for an IPO at a valuation of $2-2.5 billion. At the same time, AI-led disruption is reshaping IT and banking, driving stronger deal wins but also leaner hiring. Also inside: the surge in instant home services and how consumers are taking to them.
Topics covered
- business transformation
- mergers and acquisitions
- capital markets
- earnings growth
- AI disruption
- domestic help services
Keywords
- Sun Pharma
- Organon
- Tata Trusts
- Acko
- IPO
- AI disruption
- domestic help
- earnings growth
- capital markets
Mentioned in this episode
Organizations: Sun Pharma, Organon, Tata Trusts, Tata Sons, Acko
Places: India, West Asia
More episodes of Moneycontrol Podcast
- 5139: Acko appoints bankers, eyes $2-$2.5 Bn IPO valuation; Quick services users top 10 mn mark; And Indian IT: Why deals are not translating to revenues | Tech3
- 5138: Reliance powers ahead, dosa chain Benne in funding talks & what Sachin means for India | Editor's Picks
- 5137: Why Ranjan Pai is spending 35 crores on dosa, Gloom and doom IT earnings season, and the new age wealth managers | Tech3
- 5136: Fiscal strain of war, summer travel hotspots & what data reveals about WB turnout
- 5135: India's online gaming sector gets a referee; Slice to raise $100 million; and Infosys beats Street in Q4 but guidance disappoints
- 5134: Tesla Model YL, war stress on consumers, PC makers eye India | MC Editor's Picks
Explore listener stats, chart rankings, contacts and more on the Moneycontrol Podcast podcast page.